Bariatric Surgery vs. Medication: A 2025 Study
A 2025 study compared the effectiveness of bariatric surgery against treatment with semaglutide and tirzepatide for weight loss. Over two years, patients who underwent bariatric surgery lost an average of 25.7% of their body weight, while those on medication lost only 5.3%. Additionally, the research found that up to 70% of patients may stop taking the drugs within the first year. This highlights a significant gap between clinical trial results and real-world outcomes for these popular medications.
Conducted by researchers at New York University and funded by the American Society for Metabolic and Bariatric Surgery, the study examined two types of bariatric procedures: sleeve gastrectomy and gastric bypass.
Drug Analysis and Real-World Results
The study also analyzed semaglutide and tirzepatide, both GLP-1 receptor agonists. While earlier clinical trials showed these drugs could lead to 15–21% weight loss, real-world results were lower. As Avery Brown noted,
“clinical trials showed 15–21% weight loss with GLP-1 drugs, but in real-world settings, results were even lower, even among patients with active prescriptions for a year.”
Dr. Karan Chhabra, a bariatric surgeon at NYU Grossman School of Medicine, emphasized the need for further research:
“future studies should determine how to improve outcomes with GLP-1 drugs and identify which patients are best suited for surgery.”
These findings were presented at the annual conference of the American Society for Metabolic and Bariatric Surgery on May 28 at 2:00 PM. The study marks a critical step in understanding the effectiveness of different obesity treatments, offering new hope for patients seeking substantial and lasting weight loss.
The data underscore the advantages of bariatric surgery over medication for sustainable weight loss. This could have major implications for patients with obesity looking for effective health solutions. The results may also shape future treatment strategies and therapeutic approaches in metabolic surgery and pharmacology.